A sheet at RSNA 2023 showing AI applications developed by the radiology AI vendor Annalise.ai and commercialized outside the U.S. The company is working on gaining FDA for these and had several FDA clearances granted this past year.
Medical imaging makes up 76% of all the FDA-cleared artificial intelligence clinical algorithms used for direct patient care.
The administration said it is launching a cross-government public inquiry into “corporate greed" in medicine, with roll-up acquisitions one area of focus.